Stock Evaluator: KORU Medical Systems, Inc. (KRMD)

KORU Medical Systems, Inc. KRMD

$3.14 -0.02 -0.63%
September 14, 2026 4:00:00 PM EST November 10, 2021 Volume: 163,318
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Commentary & Analysis


Financial Summary

Share Statistics KRMD Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $145.0 $382.0 24%
Shares Out (Mil) 49.5 40.8 47%
Institutional Ownership 84.1% 83.6% 52%
Float (Mil) 34.4 34.7 39%
Beta 0.45 0.88 25%
Avg Daily Volume (000s) 171 274 43%
Price Change
(52-week)
(21.9%) 61.6% 32%
Growth KRMD Industry
Median
Percentile
(All Stocks)
Sales (5yr) 11.2% 11.8% 62%
Net Income (5yr) (16.7%) (5.8%) 23%
EPS (5yr) (14.9%) 10.4% 18
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (15.3%) (15.5%) 49%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 2 2
Current EPS ($0.020) ($0.005) $0.035
Month Ago EPS ($0.020) ($0.005) $0.035
# Rev Up 1 0 1
# Rev Down 0 0 0
Three Months Ago EPS $0.005 $0.020 $0.080
Year/Year Chg (500.0%) (91.7%) (350.0%)
Financials KRMD Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $45 $119 19%
Net Income (TTM) (Mil) ($2) ($9) 37%
EPS (TTM) ($0.039) ($0.400) 37%
Operating Cash Flow (TTM) (Mil) $1 ($3) 34%
Net Cash Flow (TTM) (Mil) $0 $1 43%
Long-Term Debt (Q1) (Mil) $3 $23 21%
Enterprise Value (Q1) (Mil) $143 $371 24%
Valuation KRMD Industry
Median
Percentile
(All Stocks)
P/B 8.05 2.80 88%
P/E na 25.4 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.5 na
Ratios KRMD Industry
Median
Percentile
(All Stocks)
Gross Margin 62.4% 58.3% 75%
Net Margin (4.0%) (6.9%) 26%
ROA (6.8%) (12.7%) 28%
ROE (10.5%) (12.3%) 27%
Liabilities to Assets 35.4% 46.0% 26%
F-Score 6 4 67%

KORU Medical Systems, Inc. did not pass any screens on 9/14/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors